Literature DB >> 2596544

Ocular Lyme borreliosis.

K E Winward1, J L Smith, W W Culbertson, A Paris-Hamelin.   

Abstract

In six patients with ocular Lyme borreliosis, bilateral granulomatous iridocyclitis and vitritis were present in five. One of these five also had bilateral optic neuritis. Another patient developed combined trochlear and facial nerve palsies. A syndrome resembling pars planitis with atypical features such as granulomatous keratic precipitates and posterior synechiae should prompt a search for Lyme borreliosis. Topical corticosteroid therapy is necessary to prevent complications of anterior segment inflammation caused by Lyme uveitis, but the benefit of systemic and periocular corticosteroids is uncertain. Oral antibiotics may be effective in treating early stages of ocular Lyme borreliosis. In later stages, intravenous antibiotic therapy is indicated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596544     DOI: 10.1016/0002-9394(89)90856-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  Lyme disease.

Authors:  D J Spalton
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  Ocular manifestations in children and adolescents with Lyme arthritis.

Authors:  H I Huppertz; D Münchmeier; W Lieb
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 3.  Analysis of ocular fluids for local antibody production in uveitis.

Authors:  J H de Boer; L Luyendijk; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

4.  Detection of antibodies to Borrelia species among patients with confirmed sarcoidosis in a region where Lyme disease is nonendemic.

Authors:  M Ishihara; T Ishida; E Isogai; K Kimura; M Oritsu; Y Matsui; H Isogai; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

5.  Spirochetal uveitis: Spectrum of clinical manifestations, diagnostic and therapeutic approach, final outcome and epidemiological data.

Authors:  Dimitrios Kalogeropoulos; Ioannis Asproudis; Maria Stefaniotou; Marilita Moschos; Constantina Gartzonika; Ioannis Bassukas; Spiros Konitsiotis; Haralampos Milionis; Georgios Gaitanis; Konstantinos Malamos; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

6.  Uveitis and systemic disease.

Authors:  A Rothova; H J Buitenhuis; C Meenken; C J Brinkman; A Linssen; C Alberts; L Luyendijk; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

7.  Intermediate uveitis and Lyme borreliosis.

Authors:  J Breeveld; A Rothova; H Kuiper
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

8.  Secondary retinitis pigmentosa and cerebral demyelination in Lyme borreliosis.

Authors:  A Karma; T A Pirttilä; M K Viljanen; Y E Lähde; C M Raitta
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

Review 9.  Current recommendations for the treatment of Lyme disease.

Authors:  L H Sigal
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 10.  Intraocular inflammation: its causes and investigations.

Authors:  Claire Hooper; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.